Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
33.21
+0.07 (0.21%)
Dec 20, 2024, 4:00 PM EST - Market closed
Apellis Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 4,131 | 7,093 | 5,718 | 4,603 | 4,332 | 1,956 | |
| Market Cap Growth | -21.59% | 24.06% | 24.22% | 6.25% | 121.45% | 163.70% | |
| Enterprise Value | 4,198 | 6,737 | 5,123 | 4,385 | 3,977 | 1,676 | |
| Last Close Price | 33.21 | 59.86 | 51.71 | 47.28 | 57.20 | 30.62 | |
| PS Ratio | 5.72 | 17.89 | 75.81 | 69.15 | 17.28 | - | |
| PB Ratio | 17.10 | 36.47 | 33.66 | 23.17 | 21.18 | 57.15 | |
| P/TBV Ratio | 14.81 | 36.47 | 33.66 | 23.17 | 21.18 | 57.15 | |
| EV/Sales Ratio | 5.87 | 16.99 | 67.92 | 65.87 | 15.87 | - | |
| Debt / Equity Ratio | 1.98 | 0.57 | 0.66 | 1.06 | 1.85 | 4.59 | |
| Asset Turnover | 0.83 | 0.51 | 0.09 | 0.07 | 0.37 | - | |
| Inventory Turnover | 3.41 | 3.15 | 6.35 | - | - | - | |
| Quick Ratio | 3.60 | 2.34 | 3.56 | 5.93 | 7.03 | 5.35 | |
| Current Ratio | 4.36 | 3.10 | 4.29 | 6.25 | 7.15 | 5.67 | |
| Return on Equity (ROE) | -106.56% | -290.14% | -353.93% | -370.20% | -288.86% | -312.20% | |
| Return on Assets (ROA) | -16.23% | -41.73% | -45.27% | -36.39% | -19.79% | -60.73% | |
| Return on Capital (ROIC) | -26.60% | -109.93% | -107.49% | -67.63% | -34.54% | -94.92% | |
| Earnings Yield | -6.05% | -7.45% | -11.41% | -16.21% | -7.96% | -15.58% | |
| FCF Yield | -4.98% | -8.40% | -9.01% | -12.26% | -3.83% | -10.88% | |
| Buyback Yield / Dilution | -6.08% | -11.84% | -25.70% | -12.32% | -20.78% | -14.40% | |
| Total Shareholder Return | -6.08% | -11.84% | -25.70% | -12.32% | -20.78% | -14.40% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.